53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
Public ClinicalTrials.gov record NCT06865079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee
Study identification
- NCT ID
- NCT06865079
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2025 (Actual)
- Primary completion
- Mar 25, 2027 (Estimated)
- Completion
- Apr 15, 2027 (Estimated)
- Last update posted
- Feb 17, 2026
2025 – 2027
United States locations
- U.S. sites
- 33
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Elite Clinical Network | Scottsdale | Arizona | 85260 | — |
| Noble Clinical Research | Tucson | Arizona | 85704 | — |
| Legent Orthopedic Hospital | Carrolton | California | 75006 | — |
| Medvin Clinical Research | Covina | California | 91722 | — |
| CORE Orthopaedic Medical Center | Encinitas | California | 92024 | — |
| Marvel Clinical Research (Elite Clinical Network) | Huntington Beach | California | 92647 | — |
| Medvin Clinical Research Center | Riverside | California | 92518 | — |
| Medvin Clinical Research Center | Tujunga | California | 91042 | — |
| Medvin Clinical Research Center | Whittier | California | 90602 | — |
| K2 Medical Research | Maitland | Florida | 32751 | — |
| Wellness Research Center | Miami | Florida | 33135 | — |
| Well Pharma Medical Research | Miami | Florida | 33173 | — |
| Las Mercedes Medical Research | Miami | Florida | 33196 | — |
| Drug Studies of America | Marietta | Georgia | 30060 | — |
| AMR Kansas City | Kansas City | Kansas | 64114 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| AMR Lexington | Lexington | Kentucky | 40509 | — |
| Accurate Clinical Research Inc. | Lake Charles | Louisiana | 70605 | — |
| Mayo Clinic (Rochester) | Rochester | Minnesota | 55905 | — |
| Las Vegas Clinical Trials | North Las Vegas | Nevada | 89030 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Hightower Clinical | Oklahoma City | Oklahoma | 73102 | — |
| University Orthopedics Center | Altoona | Pennsylvania | 16602 | — |
| University Orthopedics Center | State College | Pennsylvania | 16801 | — |
| AMR Knoxville | Knoxville | Tennessee | 37909 | — |
| Accurate Clinical Research, LLC | Baytown | Texas | 77521 | — |
| Texas Orthopedic Specialist | Bedford | Texas | 76021 | — |
| First Surgical Hospital | Bellaire | Texas | 77401 | — |
| Accurate Clinical Research | Houston | Texas | 77089 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | — |
| CenExel | Salt Lake City | Utah | 84107 | — |
| Wasatch Clinical Research | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06865079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2026 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06865079 live on ClinicalTrials.gov.